Iqvia Government Solutions Inc. has been awarded a $3,667,351.10 firm fixed price delivery order contract by the Department of Health and Human Services' Food and Drug Administration to provide hospital drug data. The contract has no set-aside designation and work will be performed in Silver Spring, Maryland through April 2025. This delivery order was issued against Iqvia's indefinite delivery, indefinite quantity contract vehicle worth up to $9 million to supply hospital drug data in support of...
This is a $11,394,396.89 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. to provide national and international pharmaceutical sales data. The contract has no set-aside designation. The contract is to support the FDA's Center for Drug Evaluation and Research in estimating trends in drug sales, pricing, and volume of distribution to inform regulatory decision-making. It provides ongoing access to pharmaceutical sales data...
Iqvia Government Solutions Inc. was awarded a $385,752.76 firm fixed price delivery order against an unspecified contract vehicle to provide the Food and Drug Administration access to over-the-counter drug utilization data. The one-year contract has a completion date of September 27, 2022 and was awarded on September 28, 2021 without a set-aside designation. As the prime contractor, Iqvia will leverage its expertise in commercial healthcare data and analytics to support the FDA's regulatory...
This is a $2,960,301.96 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. for access to over-the-counter drug utilization data. The contract has a period of performance through September 27, 2028 and is not designated as a set-aside. Iqvia Government Solutions Inc. is a for-profit organization that specializes in providing healthcare data, analytics, and technology solutions to federal agencies. This contract will enable the...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order to Iqvia Government Solutions Inc. to provide access to over-the-counter (OTC) drug utilization data services. The $2,540,550.96 contract has a completion date of September 27, 2020 and was awarded on September 28, 2017. Iqvia has provided healthcare data, analytics, and related services to various federal agencies including HHS, DoD, and DOJ through past prime and subcontracts. The...
Iqvia Government Solutions Inc. was awarded a $381,366.10 firm fixed price delivery order against an unspecified contract vehicle to provide the Food and Drug Administration access to over-the-counter drug utilization data. The one-year contract has a period of performance through September 2021 and no set-aside designation was used. The data will support the FDA's regulatory programs and efforts to protect public health by enhancing post-market drug safety surveillance and evaluation of OTC...
The Department of Health and Human Services Food and Drug Administration awarded a $539,809 purchase order contract to Iqvia Government Solutions Inc. of Mosby, Virginia to provide COVID-19 real-world evidence/data agile analytics and specialized data sets. Under this contract, Iqvia will leverage its expertise in data analytics to support the FDA's efforts to monitor the real-world impact of COVID-19 through analysis of specialized data sets. The one-year contract commenced on September 29,...
This federal contract award to Iqvia Government Solutions Inc. is for "ACCESS TO INTERNATIONAL PRESCRIPTION DRUG CONCISE GUIDE REPORTS REMIS SP-18-015" and was issued by the Office of the Assistant Secretary for Administration, a civilian agency. The contract is a $161,031.57 Firm Fixed Price Delivery Order under the Chief Information Officer Commodities and Solutions (CIO-CS) Master Contract. Iqvia, a leading provider of healthcare data and analytics, will deliver access to...
IQVIA Government Solutions Inc. was awarded a $68,332.85 firm fixed price delivery order contract by the Department of Health and Human Services' Food and Drug Administration to provide Longitudinal Prescription (LRX) Data Switch Reports. The contract has a period of performance of one year, running from December 6, 2023 through December 5, 2024. IQVIA will deliver the requested prescription drug data and reporting services from its established LRX Data Switch program to support the FDA's...
The Department of Health and Human Services Food and Drug Administration awarded a $2,461,558.38 Definitive Contract on a Time and Materials basis to Iqvia Government Solutions Inc., a healthcare data and analytics provider, to develop new, innovative methods for automation of blood product adverse event reporting under the Biologics Effectiveness and Safety (BEST) Initiative. This contract does not have a set-aside designation. Iqvia provides a range of healthcare data and analytics services to...